Who is affected by this change?

This affects Independence Blue Cross Allergy & Immunology providers on Commercial plans.

When does this change take effect?

This change is effective Apr 1, 2026.

Back to dashboard

CommercialAdministrativeLow impact

07.00.05j, In Vivo Allergy Sensitivity Testing

Independence Blue Cross·Allergy & Immunology·Medical Policy

Effective date

Apr 1, 2026

We identified it

Jun 19, 2026

Days to comply

—

Summary

The In Vivo Allergy Sensitivity Testing policy (07.00.05j) has been reissued for commercial plans effective April 1, 2026. This appears to be a routine policy reissuance rather than a substantive change to coverage or billing requirements.

Action Required

Action needed

By April 1, 2026: Billing team should review the updated policy document at the provided URL to identify any changes to coverage criteria or documentation requirements for in vivo allergy testing procedures. No immediate changes are indicated from the summary information provided.

Related policy hubs

Independence Blue Cross policies Allergy & Immunology